{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:55:11Z","timestamp":1784544911031,"version":"3.55.0"},"reference-count":21,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,1]]},"abstract":"<jats:p>OBJECTIVE. Desmopressin is an approved medical therapy for the treatment of monosymptomatic primary nocturnal enuresis. In cases of limited response to desmopressin, we have added anticholinergic therapy to desmopressin (combination therapy). To evaluate this treatment strategy, we examined the efficacy of combination therapy for primary nocturnal enuresis in desmopressin-nonresponders.<\/jats:p>\n               <jats:p>METHODS. Only patients with primary nocturnal enuresis refractory to the maximal dosage of desmopressin were enrolled. Children with lower urinary tract symptoms or bowel dysfunction were excluded, on the basis of a 3-day, 24-hour, frequency-volume chart and elimination record. Children continued to take desmopressin and were assigned randomly, in a double-blind manner, to receive either extended-release anticholinergic medication or placebo. Patients were reassessed after 1 month of therapy, with a 1-week nocturnal record.<\/jats:p>\n               <jats:p>RESULTS. Forty-one desmopressin-nonresponders were enrolled, and 7 patients were excluded because of noncompliance. The treatment groups were equally matched with respect to age, gender, functional bladder capacity, and number of wet nights per week. After 1 month of treatment, there was a significant reduction in the mean number of wet nights in the combination therapy group, compared with the placebo group. With a generalized estimating equation approach, there was a significant 66% decrease in the risk of a wet episode, compared with the placebo group.<\/jats:p>\n               <jats:p>CONCLUSIONS. This study represents the first prospective, placebo-controlled trial examining the effect of desmopressin in combination with long-acting, anticholinergic, bladder-relaxing therapy for monosymptomatic primary nocturnal enuresis.<\/jats:p>","DOI":"10.1542\/peds.2007-3691","type":"journal-article","created":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T13:45:14Z","timestamp":1225460714000},"page":"1027-1032","source":"Crossref","is-referenced-by-count":114,"title":["Combination Therapy With Desmopressin and an Anticholinergic Medication for Nonresponders to Desmopressin for Monosymptomatic Nocturnal Enuresis: A Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1542","volume":"122","author":[{"given":"Paul F.","family":"Austin","sequence":"first","affiliation":[{"name":"Division of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genoa","family":"Ferguson","sequence":"additional","affiliation":[{"name":"Division of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Surgery"},{"name":"Division of Biostatistics, Washington University School of Medicine, St Louis Children's Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Campigotto","sequence":"additional","affiliation":[{"name":"Division of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele E.","family":"Royer","sequence":"additional","affiliation":[{"name":"Division of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Coplen","sequence":"additional","affiliation":[{"name":"Division of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,11,1]]},"reference":[{"key":"2021120902402877000_R1","unstructured":"Homsy YL, Austin PF. Dysfunctional voiding disorders and nocturnal enuresis. In: Belman AB, King LR, Kramer SA, eds. Clinical Pediatric Urology. 4th ed. Florence, KY: Dunitz; 2002:345\u2013369"},{"key":"2021120902402877000_R2","doi-asserted-by":"crossref","unstructured":"Lovering JS, Tallett SE, McKendry JB. Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics.\u20081988;82(1):104\u2013106","DOI":"10.1016\/S0022-5347(17)40695-1"},{"key":"2021120902402877000_R3","doi-asserted-by":"crossref","unstructured":"Eller DA, Austin PF, Tanguay S, Homsy YL. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis. Eur Urol.\u20081998;33(suppl 3):25\u201329","DOI":"10.1159\/000052238"},{"key":"2021120902402877000_R4","unstructured":"Eller DA, Homsy YL, Austin PF, Tanguay S, Cantor A. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis. Scand J Urol Nephrol Suppl.\u20081997;183:41\u201345"},{"key":"2021120902402877000_R5","unstructured":"Kirk J, Rasmussen PV, Rittig S, Djurhuus JC. Micturition habits and bladder capacity in normal children and in patients with desmopressin-resistant enuresis. Scand J Urol Nephrol Suppl.\u20081995;173:49\u201350"},{"key":"2021120902402877000_R6","doi-asserted-by":"crossref","unstructured":"Rushton HG, Belman AB, Zaontz MR, Skoog SJ, Sihelnik S. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis. J Urol.\u20081996;156(2):651\u2013655","DOI":"10.1016\/S0022-5347(01)65775-6"},{"key":"2021120902402877000_R7","doi-asserted-by":"crossref","unstructured":"Caione P, Arena F, Biraghi M, et al. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin. Eur Urol.\u20081997;31(4):459\u2013463","DOI":"10.1159\/000474507"},{"key":"2021120902402877000_R8","doi-asserted-by":"crossref","unstructured":"Cendron M, Klauber G. Combination therapy in the treatment of persistent nocturnal enuresis. Br J Urol.\u20081998;81(suppl 3):26\u201328","DOI":"10.1046\/j.1464-410x.1998.00003.x"},{"key":"2021120902402877000_R9","doi-asserted-by":"crossref","unstructured":"Neve\u0301us T. Oxybutynin, desmopressin and enuresis. J Urol.\u20082001;166(6):2459\u20132462","DOI":"10.1016\/S0022-5347(05)65616-9"},{"key":"2021120902402877000_R10","doi-asserted-by":"crossref","unstructured":"Neve\u0301us T, La\u0308ckgren G, Tuvemo T, Olsson U, Stenberg A. Desmopressin resistant enuresis: pathogenetic and therapeutic considerations. J Urol.\u20081999;162(6):2136\u20132140","DOI":"10.1016\/S0022-5347(05)68142-6"},{"key":"2021120902402877000_R11","doi-asserted-by":"crossref","unstructured":"Radvanska E, Kovacs L, Rittig S. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis. J Urol.\u20082006;176(2):764\u2013768","DOI":"10.1016\/S0022-5347(06)00595-7"},{"key":"2021120902402877000_R12","doi-asserted-by":"crossref","unstructured":"Neve\u0301us T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol.\u20082006;176(1):314\u2013324","DOI":"10.1016\/S0022-5347(06)00305-3"},{"key":"2021120902402877000_R13","doi-asserted-by":"crossref","unstructured":"Benninga M, Candy DC, Catto-Smith AG, et al. The Paris Consensus on Childhood Constipation Terminology (PACCT) Group. J Pediatr Gastroenterol Nutr.\u20082005;40(3):273\u2013275","DOI":"10.1097\/01.MPG.0000158071.24327.88"},{"key":"2021120902402877000_R14","doi-asserted-by":"crossref","unstructured":"Rasquin-Weber A, Hyman PE, Cucchiara S, et al. Childhood functional gastrointestinal disorders. Gut.\u20081999;45(suppl 2):II60\u2013II68","DOI":"10.1136\/gut.45.2008.ii60"},{"key":"2021120902402877000_R15","doi-asserted-by":"crossref","unstructured":"Persson-Ju\u0308nemann C, Seemann O, Ko\u0308hrmann KU, Ju\u0308nemann KP, Alken P. Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis. Eur Urol.\u20081993;24(1):92\u201396","DOI":"10.1159\/000474271"},{"key":"2021120902402877000_R16","doi-asserted-by":"crossref","unstructured":"Koc\u0327sar A, Arikan N, Dinc\u0327el C. Effectiveness of oxybutynin hydrochloride in the treatment of enuresis nocturna: a clinical and urodynamic study. Scand J Urol Nephrol.\u20081999;33(2):115\u2013118","DOI":"10.1080\/003655999750016096"},{"key":"2021120902402877000_R17","doi-asserted-by":"crossref","unstructured":"Yeung CK, Chiu HN, Sit FK. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. J Urol.\u20081999;162(3):1049\u20131054","DOI":"10.1016\/S0022-5347(01)68062-5"},{"key":"2021120902402877000_R18","doi-asserted-by":"crossref","unstructured":"Yeung CK, Sit FK, To LK, et al. Reduction in nocturnal functional bladder capacity is a common factor in the pathogenesis of refractory nocturnal enuresis. BJU Int.\u20082002;90(3):302\u2013307","DOI":"10.1046\/j.1464-410X.2002.02884.x"},{"key":"2021120902402877000_R19","doi-asserted-by":"crossref","unstructured":"Kawauchi A, Tanaka Y, Naito Y, et al. Bladder capacity at the time of enuresis. Urology.\u20082003;61(5):1016\u20131018","DOI":"10.1016\/S0090-4295(02)02515-3"},{"key":"2021120902402877000_R20","doi-asserted-by":"crossref","unstructured":"Janknegt RA, Zweers HM, Delaere KP, Kloet AG, Khoe SG, Arendsen HJ. Oral desmopressin as a new treatment modality for primary nocturnal enuresis in adolescents and adults: a double-blind, randomized, multicenter study. J Urol.\u20081997;157(2):513\u2013517","DOI":"10.1016\/S0022-5347(01)65190-5"},{"key":"2021120902402877000_R21","doi-asserted-by":"crossref","unstructured":"Skoog SJ, Stokes A, Turner KL. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis. J Urol.\u20081997;158(3):1035\u20131040","DOI":"10.1016\/S0022-5347(01)64383-0"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/5\/1027\/1176853\/zpe01108001027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/5\/1027\/1176853\/zpe01108001027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T14:55:05Z","timestamp":1639061705000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/122\/5\/1027\/71503\/Combination-Therapy-With-Desmopressin-and-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,1]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,11,1]]},"published-print":{"date-parts":[[2008,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-3691","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,1]]}}}